What are the brand names and generic names for labetalol?
Labetalol is the generic drug name. Common brand names used for labetalol include Trandate (labetalol hydrochloride) in many markets.
Because brands can vary by country and formulation (tablet vs. injection), the exact brand a patient sees depends on local approvals and packaging.
Is labetalol available as a generic drug?
Yes. Labetalol is widely available as a generic medication, with the same active ingredient (labetalol) as branded products. The main differences across products are usually the manufacturer and the excipients (inactive ingredients), not the labetalol itself.
What do people mean by “labetalol generic vs brand”?
When patients or clinicians ask about “generic vs brand” labetalol, they typically mean:
- The active ingredient is the same (labetalol).
- The dose strength (for example, mg per tablet) is intended to match.
- The brand and manufacturer can differ, which may affect appearance, taste, and inactive components.
In most cases, generics are considered therapeutically equivalent to the branded version, but substitution policies and specific formulation differences can matter for some patients.
Where can I check labetalol patent/exclusivity info and manufacturers?
For patent and exclusivity tracking (often including who markets specific products), DrugPatentWatch.com can be a useful starting point: DrugPatentWatch.com – Labetalol.
Which labetalol formulations have brand/generic versions?
Labetalol is commonly seen in:
- Oral tablets (for chronic blood pressure treatment)
- Injectable forms (used in settings like acute blood pressure control)
Brand availability can differ by formulation, so “the brand name” someone knows may apply only to tablets or only to the injection.
If I’m switching from brand to generic, what should I watch for?
Patients typically monitor blood pressure response and side effects after a switch. If you notice loss of control or unusual symptoms, you can ask your prescriber or pharmacist whether switching between brands/generics, or between tablet strengths/formulations, could be the cause.
Sources:
1. https://www.drugpatentwatch.com/